Skip to content

Tectonic Therapeutics TECX Cash Flow Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$83.49M-12.6%-$74.15M-10.2%-$67.3M-2.0%-$65.98M-12.5%-$58.67M-1.2%
$1.32M-4.1%$1.38M-11.3%$1.55M-5.0%$1.63M+0.2%$1.63M-1.0%
$11.6M+10.5%$10.5M+21.7%$8.63M+15.6%$7.46M+41.4%$5.27M+51.0%
-$65.41M-8.9%-$60.08M+3.8%-$62.44M+2.8%-$64.23M-2.1%-$62.89M-6.4%
$179K+14.7%
-$130K+5.8%-$138K+2.1%-$141K-10.2%-$128K+28.5%-$179K-14.7%
-$65.61M-8.8%-$60.29M+3.8%-$62.65M+2.7%-$64.41M-2.1%-$63.07M-6.5%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Tectonic Therapeutics generate?
Tectonic Therapeutics (TECX) generated -$65.4M in operating cash flow over the trailing twelve months.
What is Tectonic Therapeutics's free cash flow?
After $230.0K of capital expenditures, Tectonic Therapeutics's free cash flow was -$65.6M over the trailing twelve months, down 4.0% year over year.
Where does Tectonic Therapeutics's cash flow data come from?
Every line is extracted from Tectonic Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.